SAM
XLRN

Sectoral Asset Management’s Acceleron Pharma XLRN Stock Holding History

Sectoral Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,000
Closed -$667K – 199
2020
Q2 		$667K Buy
+7,000
New +$675K 0.06% 116
2019
Q4 		– Sell
-227,596
Closed -$8.99M – 75
2019
Q3 		$8.99M Sell
227,596
-41,800
-16% -$1.81M 1.55% 31
2019
Q2 		$11.1M Hold
269,396
– – 1.32% 30
2019
Q1 		$12.5M Buy
269,396
+57,670
+27% +$2.53M 1.51% 24
2018
Q4 		$9.22M Sell
211,726
-87,000
-29% -$4.35M 1.25% 28
2018
Q3 		$17.1M Sell
298,726
-7,900
-3% -$388K 1.82% 19
2018
Q2 		$14.9M Buy
306,626
+82,400
+37% +$3M 1.66% 26
2018
Q1 		$8.77M Sell
224,226
-488,130
-69% -$20.7M 0.96% 41
2017
Q4 		$30.2M Buy
712,356
+107,399
+18% +$4.03M 3.78% 6
2017
Q3 		$22.6M Buy
604,957
+458
+0.1% +$15.9K 2.91% 9
2017
Q2 		$18.4M Buy
604,499
+478,099
+378% +$13.9M 2.01% 23
2017
Q1 		$3.35M Sell
126,400
-218,825
-63% -$5.77M 0.39% 44
2016
Q4 		$8.81M Sell
345,225
-136,540
-28% -$4.33M 0.98% 29
2016
Q3 		$17.4M Sell
481,765
-40,529
-8% -$1.34M 1.71% 27
2016
Q2 		$17.7M Sell
522,294
-914,941
-64% -$29.7M 1.83% 24
2016
Q1 		$37.9M Buy
1,437,235
+315,971
+28% +$9.19M 1.83% 16
2015
Q4 		$54.7M Buy
1,121,264
+509,080
+83% +$18.3M 2.33% 14
2015
Q3 		$15.2M Sell
612,184
-39,900
-6% -$1.2M 0.7% 37
2015
Q2 		$20.6M Buy
652,084
+52,900
+9% +$1.71M 0.86% 36
2015
Q1 		$22.8M Sell
599,184
-114,811
-16% -$4.57M 0.87% 37
2014
Q4 		$27.8M Sell
713,995
-12,429
-2% -$433K 1.25% 31
2014
Q3 		$22M Buy
726,424
+137,371
+23% +$3.87M 0.92% 34
2014
Q2 		$20M Buy
+589,053
New +$19.7M 0.85% 36
2014
Q1 		– Sell
-9,827
Closed -$389K – 68
2013
Q4 		$389K Buy
+9,827
New +$237K 0.02% 58

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Sectoral Asset Management's XLRN Position: Q3 2020 in Review

Sectoral Asset Management sold out of Acceleron Pharma (XLRN) in Q3 2020, closing a stake of 7,000 shares — an estimated $667K sold.

Sectoral Asset Management first reported a position in XLRN in Q4 2013 and held it in 24 quarters. The position peaked at $54.7M in Q4 2015. 238 funds tracked by Wall St. Rank hold XLRN as of Q3 2020.

  • Sectoral Asset Management reported no remaining Acceleron Pharma position as of Q3 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 7,000 Acceleron Pharma shares in Q3 2020, an estimated $667K.
  • Sectoral Asset Management first reported a position in Acceleron Pharma in Q4 2013 and held it in 24 quarters.
  • Sectoral Asset Management's Acceleron Pharma position peaked at $54.7M in Q4 2015.
  • 238 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.